The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The effect of locality of residence (LOR) and socioeconomic status (SES) on mortality in patients with squamous cell carcinoma of the head and neck (HNSCC): 20-year experience at the UPMC Hillman Cancer Center.
 
Janielle Taylor
No Relationships to Disclose
 
Yongli Shuai
No Relationships to Disclose
 
Linda Robertson
No Relationships to Disclose
 
Daniel Paul Normolle
Honoraria - NewLink Genetics
 
Robert L Ferris
Consulting or Advisory Role - Aduro Biotech; Amgen; AstraZeneca/MedImmune; Bain Capital Life Sciences; EMD Serono; GlaxoSmithKline; Iovance Biotherapeutics; Lilly; Macrogenics; Merck; Nanobiotix; Numab; Oncorus; Ono Pharmaceutical; Pfizer; PPD Global; Regeneron; Tesaro; Torque; TTMS
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; Merck; Tesaro; TTMS; VentiRx
 
Todd Bear
No Relationships to Disclose
 
Marci Lee Nilsen
No Relationships to Disclose
 
Jonas T. Johnson
No Relationships to Disclose
 
Mark Kubik
No Relationships to Disclose
 
Shaum Sridharan
No Relationships to Disclose
 
Umamaheswar Duvvuri
No Relationships to Disclose
 
Eric Wang
No Relationships to Disclose
 
Heath Devin Skinner
No Relationships to Disclose
 
David Anthony Clump
No Relationships to Disclose
 
James Ohr
No Relationships to Disclose
 
Carl Snyderman
Stock and Other Ownership Interests - Sprint Bioscience
 
Simion I. Chiosea
No Relationships to Disclose
 
Rachelle Gish-Johnson
No Relationships to Disclose
 
Seungwon Kim
No Relationships to Disclose
 
Dan Paul Zandberg
Research Funding - Aduro Biotech (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Exelixis (Inst); Macrogenics (Inst); Merck (Inst)